Industries MedTech and Pharma

Helping you develop health solutions that meet patients' and HCPs' needs

The makers of prescription drugs, medical devices, and healthcare solutions face multiple challenges from high R&D costs to lengthy approval processes. That's what makes it so crucial to anticipate your target market’s reaction before you embark on investment-intensive projects.

Conjointly has the tools and experience to help you design, run, and analyse conjoint analysis, pricing research, and product studies for medical technology and pharmaceuticals. We have experience with and access to quality patient and healthcare professional (HCP) panels worldwide.

Industries MedTech and Pharma

Helping you develop health solutions that meet patients' and HCPs' needs

The makers of prescription drugs, medical devices, and healthcare solutions face multiple challenges from high R&D costs to lengthy approval processes. That's what makes it so crucial to anticipate your target market’s reaction before you embark on investment-intensive projects.

Conjointly has the tools and experience to help you design, run, and analyse conjoint analysis, pricing research, and product studies for medical technology and pharmaceuticals. We have experience with and access to quality patient and healthcare professional (HCP) panels worldwide.

From start to finished I have been blown away by the product and service level. The price point is extremely affordable (especially given the other options for conjoint analysis), the product works great and the service has been FANTASTIC. Responses are quick and thorough and always willing to hop on the phone / add more detail. The survey has been very helpful and insightful for our business planning and I am so glad we made the decision to work with you all.

Michael Goodman, VP, Strategy & Ops at Oshi Health, Inc.
New York


Measure patients' trade-offs

Measure patients' trade-offs

Conjoint analysis is frequently used in pharma research to measure the trade-offs patients make between side effects, efficacy, length of treatment, and price. Knowing patient preferences along these lines helps companies make better R&D decisions and ultimately set appropriate pricing for treatments. 

Conjointly's automated tools, such as Generic Conjoint have been used by start-ups, research consultants, and major corporations to investigate willingness to pay and importance of product characteristics at various stages of product development.


Deliver winning products and speed up adoption

Conjointly tools (such as Claims Test and Monadic Testing) and custom services (such as Claims Combination Test) help you find the right communication angles for your products, helping boost adoption of medical innovations that extend and improve quality of life. 

Better still, most of our methods help you test multiple ideas at once, preparing you for different regulatory outcomes, and removing the need to re-test. And of course all of our tools help you run subgroup analysis to see meaningful differences in results.

Get in touch

Pharmacovigilance and compliance

Conjointly's project management team are trained in pharmacovigilance and other compliance requirements for healthcare research.

We store patient and HCP data securely, сomply with required industry regulations, and take our obligations seriously.


Access patients and health care professionals

Working with the right audience is everything in research, but finding often niche patient groups or HCPs in specific areas can be tricky. Conjointly relies on a combination of online consumer panels to source patients with common conditions, specialised HCP panels (especially for doctors and nurses), and custom outreach campaigns.

Get in touch to discuss your audience


Launching an optimal blood pressure medication based on patient insights

Time to insight: 14 hours

Download case study

Context

MedCo is a pharmaceutical company that develops an oral tablet that is used to manage blood pressure.

MedCo has identified that an injectable treatment has the potential to be more effective for its users and would like to test its feasibility on the market.

Goals

As part of strategy review, the insights team were tasked to find out:

  • What features do consumers value most about their medication? E.g. Ease of consumption, frequency of dose, price, dosage strength, number of doses per pack.
  • Would oral tablet consumers consider an injectable alternative (depending on the above factors)?

Outcomes

MedCo engaged Conjointly to perform a Generic Conjoint to test 6 key product features at 5 different price points.

Data collection of 250 responses was completed in 14 hours given the specifications of the target audience.

  • Generic Conjoint confirmed that ease of consumption was the most important feature of blood pressure medication, followed by price, dosage strength, number of doses per pack, and frequency of dose.
  • Consumers would consider an injectable type dose dependent on the other factors, but an oral tablet was favoured in most scenarios.
  • The study provided agile and actionable insights to help MedCo understand which features would best optimise an injectable treatment’s chance on the market.

Conjointly has the tools, experience and most importantly people to provide the highest level of support you and your team need to conduct agile research. We understand health industry standards and will guide you through the exciting world of insights.

Nik Samoylov image
Nik Samoylov
Conjointly Founder

Agency-quality results using marketing science

Our methods are thoroughly tested and rooted in marketing science, which means you get agency-quality results at a fraction of the cost and time investment.

Agile platform with manager-friendly dashboard

We provide state-of-the art quality analytics to suit your business. From fully automated experiments on our platform to fully custom projects of any complexity.

Deep involvement and support throughout the process

Conjointly provides reliable support throughout the service to ensure your studies meet your research and business needs.